Food and Drug Administration (FDA)

Collaboration Title	Collaboration Type	HHS Participating Agencies	NIH Participating Institutes/ Centers/ Office of the Director	Year Collaboration Originated	NIH Funding Contribution
Radiation Biodosimetry Working Group	Committee, Advisory Group, or Work Group	FDA	NIAID	2012	$0
Radiobiology Bioterrorism Research and Training Group (RABRAT)	Meeting/ Workshop	FDA, OS	NCI	2003	$0
Reciprocal Educational and Training Partnerships between FDA/CDER and the NIH Clinical Center	Training Initiative	FDA	CC, NCI, NIAID, NIDCR, NIDDK, NIMH, NINDS	2007	$0
Repurposing Food and Drug Administration Approved Drugs for a Radiation Indication Meeting Report	Other	BARDA, FDA	NIAID	2017	$0
Research Evaluation and Commercialization Hub (REACH) Review Committee	Committee, Advisory Group, or Work Group	CMS, FDA	NCI, NHLBI, NICHD, NIDA	Unknown	$0
RxNorm	Resource Development	FDA	NLM	2005	$0

Funding levels reported in the Fiscal Year 2018 Intra-Agency Collaborations Reporting System (CRS) may not be consistent with funding levels reported under the Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) at the NIH Office of Budget Website at https://report.nih.gov/funding/categorical-spending. The current process, implemented in 2008 through the Research, Condition, and Disease Categorization (RCDC) system, uses sophisticated text data mining (categorizing and clustering using words and multiword phrases) in conjunction with NIH-wide definitions used to match projects to categories. RCDC use of data mining improves consistency and eliminates the wide variability in defining the research categories reported. The definitions are a list of terms and concepts selected by NIH scientific experts to define a research category. The research category levels represent the NIH’s best estimates based on the category definitions.